SCHEMBL830177

SCHEMBL830177

COc1ccc(CS(=O)(=O)c2cc3cc(Cl)ccc3sc2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40
HTT P42858 1/20 0.40
CA2 P00918 1/20 0.40
NPY5R Q15761 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
CCR2 P41597 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
PLCG1 P19174 1/20 0.38
CNR1 P21554 1/20 0.38
CLK1 P49759 1/20 0.38
CLK2 P49760 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MAPK1 P28482 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL830871 0.91 MEN1 (0.42) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL830855 0.86 CA2 (0.40) CA2L3MBTL1PLCG1CLK1POLB
SCHEMBL830994 0.84 GCKR (0.42) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL830154 0.83 CA2 (0.49) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL830271 0.80 NFE2L2 (0.44) MEN1KMT2AALDH1A1CYP2C19CA2
SCHEMBL830272 0.80 NFE2L2 (0.44) MEN1KMT2AALDH1A1CYP2C19CA2
SCHEMBL830602 0.80 NFE2L2 (0.44) MEN1KMT2AALDH1A1CYP2C19CA2
SCHEMBL830672 0.79 SULT1A1 (0.43) MEN1KMT2AALDH1A1CA2L3MBTL1
SCHEMBL830450 0.79 CYP3A4 (0.40) MEN1KMT2AALDH1A1CA2TP53
SCHEMBL829697 0.79 F10 (0.38) MEN1KMT2AALDH1A1CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US claimed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US claimed
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof SULT1E1, STS, CCNE1 MEN1 979/4885KMT2A 484/4885ALDH1A1 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.